
|Articles|March 22, 2019
Universal Medica Group and EVERSANA Partner
Advertisement
Universal Medica Group-consulting form for healthcare and pharma-and EVERSANA-provider of commercial services in life sciences-announced that they have entered into a partnership for the life sciences and healthcare industry.
The companies plan to provide medical information and programs-with infrastructure, technology, workflows, and clinical staffing-and pharmacovigilance services throughout Europe, Asia, and North, Central, and South America.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
2
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
3
FDA Announces New Biosimilar-Targeted Draft Guidance
4
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer
5





